TAS-OX
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAS-OX, covering 2021-07-20 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer [Phase 2]